Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShare-based Compensation (IS)Shares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

CureVac (CVAC) Tax Provisions (2019 - 2025)

Historic Tax Provisions for CureVac (CVAC) over the last 7 years, with Q3 2025 value amounting to -$40.2 million.

  • CureVac's Tax Provisions fell 1241.25% to -$40.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $27.4 million, marking a year-over-year increase of 17280.78%. This contributed to the annual value of $30.7 million for FY2024, which is 1429349.59% up from last year.
  • According to the latest figures from Q3 2025, CureVac's Tax Provisions is -$40.2 million, which was down 1241.25% from $459575.6 recorded in Q2 2025.
  • In the past 5 years, CureVac's Tax Provisions ranged from a high of $67.5 million in Q4 2024 and a low of -$40.2 million during Q3 2025
  • In the last 5 years, CureVac's Tax Provisions had a median value of -$14938.8 in 2022 and averaged -$598748.3.
  • Data for CureVac's Tax Provisions shows a peak YoY increase of 2706867.75% (in 2024) and a maximum YoY decrease of 54684559.42% (in 2024) over the last 5 years.
  • CureVac's Tax Provisions (Quarter) stood at $1.2 million in 2021, then plummeted by 124.09% to -$291790.7 in 2022, then soared by 185.18% to $248542.1 in 2023, then soared by 27068.68% to $67.5 million in 2024, then plummeted by 159.47% to -$40.2 million in 2025.
  • Its last three reported values are -$40.2 million in Q3 2025, $459575.6 for Q2 2025, and -$451258.4 during Q1 2025.